Clinical Trial Update: Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension [Phase 4]

View source ↗

Summary

A Phase IV, randomized, double-masked trial comparing morning versus evening dosing of the fixed-dose combination Travoprost 0.004% / Timolol Maleate 0.5% in pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Timolol maleate (Timolol maleate)
• Travoprost (Travoprost (isomer-free))

Snippet

Sponsor: Alcon Research | Conditions: Open-angle Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED